Prospective Longitudinal Monocentric Study to Evaluate the Syde® Digital Endpoint in Patients With Multiple Sclerosis - Trial NCT06346704
Access comprehensive clinical trial information for NCT06346704 through Pure Global AI's free database. This phase not specified trial is sponsored by SYSNAV and is currently Recruitment Completed. The study focuses on Multiple Sclerosis. Target enrollment is 61 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
SYSNAV
Timeline & Enrollment
N/A
Apr 25, 2024
Nov 30, 2026
Primary Outcome
Longitudinal change of 95th centile of stride velocity
Summary
The study aims to assess the validity of real-world activity monitoring by the Syde® wearable
 device in subjects with multiple slclerosis. The Syde® collected data will be compared to
 on-site conventional clinical endpoints for MS pathology (EDSS, FSS and T25FWT). Subjects
 with multiple sclerosis will be assessed every 6 months for 2 years.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06346704
Non-Device Trial